The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of regorafenib in patients with non-adipocytic soft tissue sarcoma (NASTS): Evaluation of heterogeneity of treatment effect on the updated analysis of pooled cohorts.
 
Marie-Cecile Le Deley
No Relationships to Disclose
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; Karyopharm Therapeutics; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Jennifer Wallet
No Relationships to Disclose
 
Francois Bertucci
No Relationships to Disclose
 
Emmanuelle Bompas
No Relationships to Disclose
 
Thomas Brodowicz
Honoraria - PharmaMar
Consulting or Advisory Role - Bayer; Deciphera; PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Loic Chaigneau
No Relationships to Disclose
 
Christine Chevreau
Consulting or Advisory Role - Bristol-Myers Squibb; ESAÏ; GlaxoSmithKline; Ipsen; Pfizer
Travel, Accommodations, Expenses - IPSEN
 
Emilie Decoupigny
No Relationships to Disclose
 
Antoine Italiano
Honoraria - Bayer; Daiichi Sankyo; Epizyme; IPSEN; Lilly; Novartis; Roche
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Immune Design; Lilly; Roche
Research Funding - AstraZeneca/MedImmune; Bayer; Merck Serono; Merck Serono; MSD Oncology; PharmaMar; Roche
Patents, Royalties, Other Intellectual Property - BMS
 
Bernadette Lieg-Atzwanger
No Relationships to Disclose
 
Olivier Mir
Employment - Amgen
Stock and Other Ownership Interests - Amgen; Amplitude Surgical; Ipsen; Transgene
Honoraria - Roche
Consulting or Advisory Role - Janssen; Lilly; Lundbeck; Pfizer; Roche
Speakers' Bureau - Lilly; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Blueprint Medicines (Inst); Ipsen
Travel, Accommodations, Expenses - Pfizer; Roche
 
Sophie Piperno-Neumann
Consulting or Advisory Role - Immunocore
Research Funding - MSD (Inst); Novartis (Inst)
 
Julien Thery
No Relationships to Disclose
 
Axel Le Cesne
Honoraria - Bayer; Deciphera; PharmaMar
 
Nicolas Penel
Research Funding - Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar